X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AMAR REMEDIES with Colgate - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs COLGATE - Comparison Results

COLGATE 
   Change

Colgate is present in oral care, personal care and household care products with oral care contributing more than 90% to overall revenues. Colgate dominates in this core business with market shares of 54.5% in toothpastes and 38.2% in toothbrushes. Th... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMAR REMEDIES COLGATE AMAR REMEDIES/
COLGATE
 
P/E (TTM) x -0.5 39.8 - View Chart
P/BV x 0.1 20.2 0.3% View Chart
Dividend Yield % 0.0 2.1 -  

Financials

 AMAR REMEDIES   COLGATE
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
COLGATE
Mar-18
AMAR REMEDIES/
COLGATE
5-Yr Chart
Click to enlarge
High Rs1641,176 14.0%   
Low Rs86970 8.9%   
Sales per share (Unadj.) Rs261.6154.0 169.9%  
Earnings per share (Unadj.) Rs17.424.8 70.3%  
Cash flow per share (Unadj.) Rs22.330.5 73.0%  
Dividends per share (Unadj.) Rs024.00 0.0%  
Dividend yield (eoy) %02.2 0.0%  
Book value per share (Unadj.) Rs100.756.1 179.7%  
Shares outstanding (eoy) m26.16271.99 9.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.57.0 6.9%   
Avg P/E ratio x7.243.3 16.6%  
P/CF ratio (eoy) x5.635.2 16.0%  
Price / Book Value ratio x1.219.1 6.5%  
Dividend payout %096.9 0.0%   
Avg Mkt Cap Rs m3,270291,777 1.1%   
No. of employees `000NA2.4 0.0%   
Total wages/salary Rs m1633,059 5.3%   
Avg. sales/employee Rs ThNM17,348.7-  
Avg. wages/employee Rs ThNM1,267.3-  
Avg. net profit/employee Rs ThNM2,789.4-  
INCOME DATA
Net Sales Rs m6,84441,880 16.3%  
Other income Rs m21388 5.4%   
Total revenues Rs m6,86542,268 16.2%   
Gross profit Rs m1,13111,124 10.2%  
Depreciation Rs m1281,565 8.2%   
Interest Rs m3980-   
Profit before tax Rs m6269,947 6.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-50-117 42.9%   
Tax Rs m1213,097 3.9%   
Profit after tax Rs m4556,734 6.8%  
Gross profit margin %16.526.6 62.2%  
Effective tax rate %19.331.1 62.1%   
Net profit margin %6.616.1 41.3%  
BALANCE SHEET DATA
Current assets Rs m4,90410,607 46.2%   
Current liabilities Rs m3,5819,828 36.4%   
Net working cap to sales %19.31.9 1,038.9%  
Current ratio x1.41.1 126.9%  
Inventory Days Days12420 628.9%  
Debtors Days Days10018 571.6%  
Net fixed assets Rs m1,68913,045 12.9%   
Share capital Rs m262272 96.3%   
"Free" reserves Rs m2,35814,974 15.7%   
Net worth Rs m2,63515,246 17.3%   
Long term debt Rs m5070-   
Total assets Rs m6,86225,639 26.8%  
Interest coverage x2.6NM-  
Debt to equity ratio x0.20-  
Sales to assets ratio x1.01.6 61.1%   
Return on assets %12.426.3 47.3%  
Return on equity %17.344.2 39.1%  
Return on capital %31.064.5 48.1%  
Exports to sales %4.00-   
Imports to sales %00-   
Exports (fob) Rs m273NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m2731,876 14.6%   
Fx outflow Rs m23,373 0.1%   
Net fx Rs m271-1,498 -18.1%   
CASH FLOW
From Operations Rs m-3136,939 -4.5%  
From Investments Rs m-489-2,073 23.6%  
From Financial Activity Rs m769-3,798 -20.2%  
Net Cashflow Rs m-331,068 -3.0%  

Share Holding

Indian Promoters % 25.5 0.0 -  
Foreign collaborators % 0.0 51.0 -  
Indian inst/Mut Fund % 9.2 7.0 131.4%  
FIIs % 0.0 20.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 65.3 22.1 295.5%  
Shareholders   13,061 131,569 9.9%  
Pledged promoter(s) holding % 99.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMAR REMEDIES With:   BAJAJ CONSUMER CARE  GODREJ CONSUMER  MARICO  P&G HYGIENE  LINC PEN & PLASTICS  

Compare AMAR REMEDIES With:   UNILEVER PLC. (UK)  P&G (US)  HYPERMARCAS (Brazil)  



Today's Market

Sensex Ends 234 Points Higher; Healthcare and Realty Stocks Rally(Closing)

After opening the day on a flat note, Indian share markets witnessed buying interest during closing hours and ended higher.

Related Views on News

COLGATE Announces Quarterly Results (4QFY19); Net Profit Up 4.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, COLGATE has posted a net profit of Rs 2 bn (up 4.7% YoY). Sales on the other hand came in at Rs 12 bn (up 5.7% YoY). Read on for a complete analysis of COLGATE's quarterly results.

COLGATE Announces Quarterly Results (3QFY19); Net Profit Up 12.6% (Quarterly Result Update)

Jan 24, 2019 | Updated on Jan 24, 2019

For the quarter ended December 2018, COLGATE has posted a net profit of Rs 2 bn (up 12.6% YoY). Sales on the other hand came in at Rs 11 bn (up 6.4% YoY). Read on for a complete analysis of COLGATE's quarterly results.

COLGATE Announces Quarterly Results (2QFY19); Net Profit Up 10.6% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, COLGATE has posted a net profit of Rs 2 bn (up 10.6% YoY). Sales on the other hand came in at Rs 12 bn (up 7.7% YoY). Read on for a complete analysis of COLGATE's quarterly results.

COLGATE Announces Quarterly Results (1QFY19); Net Profit Up 39.0% (Quarterly Result Update)

Jul 30, 2018 | Updated on Jul 30, 2018

For the quarter ended June 2018, COLGATE has posted a net profit of Rs 2 bn (up 39.0% YoY). Sales on the other hand came in at Rs 10 bn (down 6.9% YoY). Read on for a complete analysis of COLGATE's quarterly results.

COLGATE Announces Quarterly Results (4QFY18); Net Profit Up 32.4% (Quarterly Result Update)

May 23, 2018 | Updated on May 23, 2018

For the quarter ended March 2018, COLGATE has posted a net profit of Rs 2 bn (up 32.4% YoY). Sales on the other hand came in at Rs 11 bn (down 7.2% YoY). Read on for a complete analysis of COLGATE's quarterly results.

More Views on News

Most Popular

I Believe this is the Best Stock to Buy Today(Profit Hunter)

Jul 3, 2019

The languishing small cap space is currently offering a very fertile market to pick up bargains at very attractive prices. This is a perfect opportunity ripe for the picking.

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound(Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors(The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

Union Budget 2019-2020: More Style Over Substance(The 5 Minute Wrapup)

Jul 5, 2019

Did the Union Budget announce measures to stimulate the economy and bolster corporate earnings growth?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES - K.S.OILS LTD COMPARISON

COMPARE AMAR REMEDIES WITH

MARKET STATS